WHO Drug Information Vol. 16, No. 2, 2002
(2002; 91 pages) View the PDF document
Table of Contents
Open this folder and view contentsHerbal Medicines
Open this folder and view contentsCurrent Topics
Open this folder and view contentsGood Clinical Practices
Open this folder and view contentsSafety Information
Open this folder and view contentsRegulatory Action
Open this folder and view contentsEssential Medicines
Close this folderRecent Publications and Sources of Information
View the documentGenomics and world health
View the documentLegal status of traditional and complementary medicine
View the documentKinetoplastid research source launched
View the documentEndocrine disrupting chemicals
View the documentProposed International Nonproprietary Names: List 87
 

Kinetoplastid research source launched

Kinetoplastid Biology and Disease (KBD) is an electronic publication which aims to strengthen ties between research and clinical/field applications, increasing dialogue between bench scientists, theoreticians and planners, and the professionals in the field. KBD accepts basic science, epidemiologic, public health, clinical, veterinary and agricultural papers on trypanosomiasis, leishmaniasis and related disease which meet the criteria of peer review.

The advent of KBD enables the free dissemination of scientific information about kinetoplastid diseases and their control. This is critical, since most scientific journals are not free and even the ones with cheaper subscription rates may not be accessible to researchers, clinicians, and field researchers in the poorest and affected developing countries. Moreover, the journal will serve as a focus in which the whole kinetoplastid community can participate: to educate, notify and debate about progress and direction. We hope our new journal will serve as a vehicle to promote pragmatic research and as a practical first step in tackling some of the communication difficulties that face those concerned with the eradication of these diseases.

KBD is created as peer-review journal, freely available to anyone in the world with a networked computer. KBD is published by BiomedCentral (www.biomedcentral.com), and has a world class editorial board (http://www.kinetoplastids.com/edboard/). It will be indexed by most of the major scientific indexing services such as PubMed. Articles will be available in html and.pdf formats. KBD is supported by the Vice-Presidencia de Desenvolvimento Institucional, Informacao e Comunicacao” and the “Instituto Oswaldo Cruz” of the Oswaldo Cruz Foundation. The journal is recipient of a Soros Foundation award for promoting open publishing.

In its first issue, Kinetoplastid Biology and Disease presents:

• Combating Kinetoplastid diseases, http://www.kinetoplastids.com/content/pdf/1475-9292-1-6.pdf

• Salivaria or Stercoraria? The Trypanosoma rangeli dilemma, http://www.kinetoplastids.com/content/pdf/1475-9292-1-5.pdf

• What can we hope to gain for trypanosomiasis control from molecular studies on tsetse biology ? http://www.kinetoplastids.com/content/1/1/4

• From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality. http://www.kinetoplastids.com/content/pdf/1475-9292-1-3.pdf

• PCR identification of Trypanosoma lewisi, a common parasite of laboratory rats, http://www.kinetoplastids.com/content/1/1/2

• Molecular determinants and regulation of Leish-mania virulence, http://www.kinetoplastids.com/content/1/1/1


Papers and feedback may be sent to kbd@trypanosome.com

Kinetoplastid Biology and Disease is available from: http://www.kinetoplastids.com.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018